Fundamental, Research

Life Science Tools and Services Q4 Earnings Preview: Low Visibility for Most in the Near Term

Sel Hardy, VP of Equity Research
23 January 2024

Summary

LSTS companies in the US will report their Q4 2023 earnings soon. We expect their Q4 2023 EPS to decline around 11% Y/Y, with some variation across companies. The LSTS sub-industry faced increasing challenges in the global operating environment through the end of 2023. We are monitoring the Red Sea shipping crisis for its implications. We will watch for commentaries on the impact of recent developments on the companies' Q1 performance so far. Shipping delays and increasing costs are a concern if the crisis continues.


Want to learn more? Download the Report.

Solutions

Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.

Related Insights

Life Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023

Life Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023

Several Life Science Tools and Services (LSTS) companies had a tough Q2, negatively...
Read more